Abstract
Objetives
Analysis of the results on the treatment of esophageal cancer by transthoracic esophagectomy by a multidisciplinary team of surgeons and oncologists.
Methods
Between January 1990 and December 2009, 100 consecutive patients underwent transthoracic esophagectomy. Data were collected prospectively and clinical, pathological and histological features of the tumors were analyzed as well as the results of postoperative morbidity and mortality.
Results
The average patient age was 55 years (range 31–83 years). In 59 cases the tumor was located in the lower third and in 41 cases in the middle third. Forty-six patients had adenocarcinoma and 54 squamous cell carcinoma. In 54 cases radio-chemotherapy was planned preoperatively. Classification according to pathological tumor stage was: stage 0 in 21 patients, stage I in 10 patients, stage IIa in 28, stage IIb in 9, stage III in 21 and stage IV in 11. The mean number of lymph nodes examined was 14 (range 0–28). Hospital mortality occurred in 4 cases and postoperative complications in 29 patients (33%). The most frequent postoperative complication was pulmonary complications in 17 cases. The average hospital stay was 15.2 days (range 10–40 days)
Conclusions
The results of esophageal cancer have been improved in recent years due to the formation of multidisciplinary teams in this pathology. In our study we have shown that the results obtained with the transthoracic technique for cancer of the esophagus are within the ranges reported in the literature for teams with high prevalence of the disease.
Similar content being viewed by others
References
van Heijl M, van Lanschot JJ, Koppert LB et al (2008) Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus. (CROSS). BMC Surg 8:21
Hagen JA, DeMeester SR, Peters JH et al (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234:520–530
Hennequin C, Gayet B, Sauvanet A et al (2001) Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus. Int J Radiat Oncol 3:657–664
Pera M (2003) Niveles de calidad exigibles en cuanto a tecnología y procedimientos en la cirugía del cáncer de esófago. Cir Esp 74:256–261
Prytherch DR, Whiteley MS, Higgins B et al (1998) POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity. Br J Surg 85:1217–1220
Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the esophagogastric junction. Br J Surg 85:1457–1459
American Joint Committee on Cancer (AJCC) (2002) Cancer staging handbook: TNM classification of malignant tumours, 6th edn. Springer, New York
Becker K, Mueller JD, Schumacher C et al (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98:1521–1530
Luketich JD, Friedman DM, Weigel TL (1999) Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 68:1133
Abate E, DeMeester SR, Zehetner J et al (2010) Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg 210:428–435
Noble F, Bailey D; SWCIS Upper Gastrointestinal Tumour Panel, Tung K, Byrne JP (2009) Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study. Clin Radiol 64:699–705
Ott K, Weber W, Siewert JR (2006) The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis Esophagus 19:433–442
Tong DK, Law S, Kwong DL et al (2010) Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17: 2184–2192
Urschel JD, Vasan H (2002) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538–543
Sutton P, Clark P (2000) Neo-adjuvant treatment for esophageal cancer. GI Cancer 3:231–238
Geh JI, Crellin A, Glynne R (2001) Preoperative neoadjuvant chemoradiotherapy in esophageal cancer. Br J Surg 88:338–356
Gluch L, Smith RC, Bambach C, Brown AR (1999) Comparison of outcomes following transhiatal or Ivor Lewis esophagectomy for esophageal carcinoma. World J Surg 23:271–276
Chu KM, Low SY, Fok M, Wong J (1997) A prospective randomized comparison of transhiatal and transthoracic resection for lower third esophageal carcinoma. Am J Surg 174:320–324
Orringer MB (1987) Transthoracic versus transhiatal esophagectomy: what difference does it makes. Ann Thorac Surg 44:116–117
Hernández Lizoain JL, Cienfuegos JA, Pardo F et al (1998) Preoperative chemotherapy followed by esophagectomy compared with surgery alone in the treatment of squamous cell carcinoma of the esophagus. Rev Esp Enferm Dig 90:275–290
Torramadé JR, Hernández-Lizoain JL, Zornoza G et al (1992) Cancer of the esophagus: the results of surgery, anatomopathological study and patient survival. Rev Esp Enferm Dig 82:388–393
Beitler AL, Urschel JD (1998) Comparison of stapled and hand-sewn esophagogastric anastomoses. Am J Surg 175:337–340
Jamieson CG, Mathew G (1999) Surgical management of esophageal cancer: the Western experience. In: Daly JM, Henessy TPJ, Reinolds JV (eds) Management of upper gastrointestinal cancer. WB Saunders, London, pp 183–199
Zafirellis KD, Fountoulakis A, Dolan K et al (2002) Evaluation of POSSUM in patients with oesophageal cancer undergoing resection. Br J Surg 89:1150–1155
Dutta S, Horgan PG, McMillan DC (2010) POSSUM and its related models as predictors of postoperative mortality and morbidity in patients undergoing surgery for gastro-oesophageal cancer: a systematic review. World J Surg 34:2076–2082
Karl RC, Schreiber R, Boulware D et al (2000) Factors affecting morbidity, mortality and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg 231:635–643
Adham M, Baulieux J, Mornex F et al (2000) Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus. Cancer 89:846–854
Laterza E, de’ Manzoni G, Tedesco P et al (1999) Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase II study. Ann Surg Oncol 6:777–784
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Valentí, V., Hernández-Lizoain, J.L., Martínez-Regueira, F. et al. Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients. Multidisciplinary approach. Clin Transl Oncol 13, 899–903 (2011). https://doi.org/10.1007/s12094-011-0752-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-011-0752-4